• Submission

Journal of Pharmaceutical Research International

  • About
    • About the Journal
    • Submissions & Author Guideline
    • Articles in Press
    • Editorial Policy
    • Editorial Board Members
    • Reviewers
    • Propose a Special Issue
    • Reprints
    • Subscription
    • Membership
    • Publication Ethics and Malpractice Statement
    • Digital Archiving Policy
    • Contact
  • Archives
  • Indexing
  • Publication Charge
  • Books
  • Testimonials
Advanced Search
  1. Home
  2. Archives
  3. 2020 - Volume 32 [Issue 21]
  4. Original Research Article

Submit Manuscript


Subscription



  • Home Page
  • Author Guidelines
  • Editorial Board Member
  • Editorial Policy
  • Propose a Special Issue
  • Membership

The International Legal Problems of Ensuring the Availability of Medications in Conditions of the COVID-19

  • Olga Bakalinska
  • Nataliia Myronenko
  • Olena Stefan
  • Yuliya Atamanova
  • Olga Orliuk

Journal of Pharmaceutical Research International, Page 40-57
DOI: 10.9734/jpri/2020/v32i2130751
Published: 3 September 2020

  • View Article
  • Download
  • Cite
  • References
  • Statistics
  • Share

Abstract


In the context of the COVID-19 coronavirus pandemic, the risks of individual pharmaceutical market players or groups of players taking measures to supply medications that may lead to an economically unjustified increase in drug prices or artificially create a shortage of products are increasing worldwide.


Aims: Finding the best way to protecting intellectual property rights for medications in conditions of the COVID-19 coronavirus pandemic.


Methods: The methodological basis of the study was formed by an integral and coordinated system of scientific methods that contributed to the study of such a complex socio-legal phenomenon as the availability of medicinal products in conditions of the COVID-19 coronavirus pandemic. At the same time, a synergistic approach was applied, which combined the special research methods of various branches of law, pharmaceutical science and practice.


Results: The article reveals and identifies the distinctive features of using patent protection measures and parallel imports in the drug markets of various countries of the world and the impact of the TRIPS Agreement on the availability of medications for the public in conditions of the COVID-19.


Conclusion: For many countries, including Ukraine, the introduction of parallel imports can be efficient in the short term. Allowing parallel imports of medications has significantly fewer negative consequences for the copyright holder, since the improper quality of the products, in which the invention is used without the use of a trademark, most often does not affect the business reputation of the patent owner. Nevertheless, the chosen model of permitting the use of parallel imports to ensure the availability of medications in Ukraine remains a topical and controversial issue that requires a lot of professional discussion. Legislators should be very careful and cautious about the development and implementation of the institution of parallel imports of medications to Ukraine paying attention to the development of a whole system of quality and transparency control for procedures related to parallel imports to this country.


Keywords:
  • Pharmaceutical market
  • COVID-19
  • medications
  • patent protection
  • parallel imports
  • medical law
  • Full Article - PDF
  • Review History

How to Cite

Bakalinska, O., Myronenko, N., Stefan, O., Atamanova, Y., & Orliuk, O. (2020). The International Legal Problems of Ensuring the Availability of Medications in Conditions of the COVID-19. Journal of Pharmaceutical Research International, 32(21), 40-57. https://doi.org/10.9734/jpri/2020/v32i2130751
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver

References

WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it.
(Accessed 10 August 2020)
Available:https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

ArcGIS. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Johns Hopkins University.
(Accessed 10 August 2020)
Available:https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

Pro zahody schodo stabilizatsii tsin na tovary, scho maiut` istotnu sotsialnu znachushchist`, tovary protyepidemiologichnogo pryznachennia. Resolution of Government of Ukraine, No. 341. Official Gazette of Ukraine. 2020;39:29. Ukrainian.

LB.UA. ‘Ukrainets pytalsia vyvezti v Polshu bolee 10.5 tys. Meditsinskih masok’; 2020. Russian.
(Accessed 10 August 2020)
Available:https://lb.ua/society/2020/03/11/452215_ukrainets_pitalsya_vivezti_polshu.html

LB.UA. ‘Na zakarpatie predotvratili kontrabandu meditsinskih masok v Rumyniiu`, 4 March 2020. Russian. (Accessed 10 August 2020)
Available:https://lb.ua/society/2020/03/04/451631_zakarpate_predotvratili.html

Lexchin J. Canada and access to medicines in developing countries: intellectual property rights first. Global Health. 2013;9:42.
Available:https://doi.org/10.1186/1744-8603-9-42

Correa С. Integrating Public Health Concerns into Patent Legislation in Developing Countries. Geneva: The South Centre; 2002.

Yevkov AM. Problematyka pravovogo reguliuvannia paraltlnogo importu tovariv, yaki mistiat` ob`iekty intelertualnoi vlasnosti, ta vycherpannia vykluchnyh prsv u zakonodavstvi Ukrainy. Scientific Bulletin of the Uzhgorod National University, LAW Series. 2014;29(1):139-144. Ukrainian.

Myronyshyna O. Economichni aspecty functsionuvannia mizhnarodnoi systemy patentnogo zahystu u farmatsevtychnomu sektori. Bulletin of Lviv University, Economics Series. 2008;40:158-63. Ukrainian.

Bugayenko NM, editor. Zvit z naukovo-doslidnoi roboty “Mizhnarodnyi dosvid funktsionuvaniia rynkiv oryginalnyh likarskyh zasobiv ta dzhenerykiv”. Kyiv: Anti-Monopoly Committee; 2015. Ukrainian.

Ugoda pro torgovelni aspekty prav intelektualnoi vlasnosti. International document. WTO. Verhovna Rada Ukrainy ; 1994. Ukrainian.
(Accessed 16 July 2020)
Available:http://zakon0.rada.gov.ua/laws/show/981_018/page5

Potekhina V. Intelektualna vlasnist. N.d. Ukrainian.
(Accessed 16 July 2020)
Available:http://uchebnik-online.net/book/870-intelektualna-vlasnist-navchalnij-posibnik-vo-potyexina.html

Polonskyi V. Farmatsevticheskie patenty: ekonomicheskie I sotsialnyie aspekty. Pharmateka Publishers. 2000;4(40):19-23.

Bakalinska OO, Atamanova Yu Y, Orliuk OP. International experience of using parallel imports to ensure the accessibility of drugs. International Journal of Recent Technology and Engineering (IJRTE). 2019;8(4S):52-56.

Grover Anand. Promotion and Protection of All Human Rights, Civil, Political, Economic, Social and Cultural Rights, Including the Right to Development. United Nations; 2009. A/HRC/11/12.
(Accessed 16 July 2020)
Available:http://www2.ohchr.org/english/bodies/hrcouncil/docs/11session/A.HRC.11.12_en.pdf

United Nations. Rukovodstvo po nadlezhaschei praktike uluchsheniia dostupa k lecheniyu putem priminenia gibkih polozheniy soglashenia WTO TRIPS v oblasti obschestvennogo sdravoohranenia. UN Development Program; 2010. Russian.
(Accessed 16 July 2020)
Available:http://www.undp.org/content/dam/undp/library/hivaids/English/TRIPS-UNDP-Russian.pdf

The Impact of Higher Standards in Patent Protection for Pharmaceutical Industries under the TRIPS Agreement. A Comparative Study of China and India. Helsinki: United Nations University; 2008.
(Accessed 16 July 2020)
Available:http://www.wider.unu.edu/publications/working-papers/research papers/2008/en_GB/rp2008-36/

Biswajit Dhar, Rao C.Niranjan. Transfer of Technology for Successful Integration into the Global Economy: A Case Study of the Pharmaceutical Industry in India. United Nations. New York and Geneva; 2002.

(Accessed 16 July 2020)
Available:https://unctad.org/en/Docs/iteipcmisc22_en.pdf

Mindrul A. Znachennia Ugody pro torgovelni aspecty prav intellectual`noi vlasnosti u pravovomu reguliuvanni farmatsevtychnoi sfery. Ukrainian Law. 2011;3:8-11. Ukrainian.

Patent Applications by Country of Origin (1995–2008). ITA. Country Rankings. N.d. (Accessed 16 July 2020)
Available:https://photius.com/rankings/patent_applications_by_country_1995-2008.html

Davey Sheila, editor. The 10/90 Report on Health Research. Geneva: Global Forum for Health Research; 2000.
(Accessed 16 July 2020)
Available:http://announcementsfiles.cohred.org/gfhr_pub/assoc/s14791e/s14791e.pdf

Gathii JT. The Legal Status of the Doha Declaration on TRIPS and Public Health Under the Vienna Convention on the Law of Treaties. Harvard Journal of Law & Technology. 2002;15(2):292-317.
(Accessed 16 July 2020)
Available:http://jolt.law.harvard.edu/articles/pdf/v15/15HarvJLTech291.pdf

WTO. The Doha Declaration on the Trips Agreement and Public Health.
(Accessed 16 July 2020)
Available:https://www.who.int/medicines/areas/policy/doha_declaration/en/

The Patents Act: Law of Parliament in the Twenty-first Year of the Republic of India, 1970.
(Accessed 16 July 2020)
Available:http://www.ipindia.nic.in/acts-patents.htm

Commission on Intellectual Property Rights. Report of the Integrating Intellectual Property Rights and Development Policy. London; 2002.
(Accessed 16 July 2020)
Available:http://www.iprcommission.org/papers/pdfs/final_report/CIPRfullfinal.pdf

Proekt Zakona Ukrainy. Pro Vnesennia Zmin do Deiakyh Zakonodavchyh Aktiv Ukrainy Schodo Stvorennia Natsionalnogo Organu Intelektualnoi Vlasnosti. 2019; 2255. Ukrainian.
(Accessed 16 July 2020)
Available:http://w1.c1.rada.gov.ua/pls/zweb2/webproc4_1?pf3511=67060

Talibov OB. Dzheneriki I ekvivalentnost` lekarstvennyh preparatov. 2005, November 18, Medicus.ru. Russian.
(Accessed 16 July 2020)
Available:http://www.medicus.ru/pharmacology/patient/dzheneriki-i-ekvivalentnost-lekarstvennyh-preparatov-24989.phtml

Trofimova E. Differentsirovannoie tsenoobrazovanye na pharmacevticheskom rynke v razreze razlichnykh stran. Remedium. 2013;2:8-18. Russian.
(Accessed 16 July 2020)
Available:https://cyberleninka.ru/article/n/differentsirovannoe-tsenoobrazovanie-na-farmatsevticheskom-rynke-v-razreze-razlichnyh-stran/viewer

Kosse I, Betliy O. Reguliuvannia tsin na likarski zasoby v krainah ES. Regulation of Drug Prices in the EU Countries. Kyiv: Institute for Economic Research and Political Advice. N.d. Ukrainian.
(Accessed 16 July 2020)
Available:http://www.ier.com.ua/files/publications/Policy_Briefing_Series/2012/Policy_brief_HC2.pdf

Nizhegorodtsev TV. Report On the Results of the Assessment of the Availability of Medications Based on the Analysis of Consumer Prices and Drugs Pricing in the Russian Federation (Including the Entities of the Russian Federation) and in Comparable Markets of Some Countries, Including Those That are Part of the CIS, the European Union and the BRICS. Moscow. Federal Anti-Monopoly Service of the Russian Federation; 2014. Russian.
(Accessed 16 July 2020)
Available:http://fas.gov.ru/upload/documents/archive/e959344965ea641827834e53598b0c10.pdf

World Intellectual Property Organization. Study on the Role of Patent Systems in Promoting Innovative Medicines, and in Fostering the Technology Transfer Necessary to Make Generic and Patented Medicines Available in Developing Countries and Least Developed Countries; 2014. No. SCP/21/8.
(Accessed 16 July 2020)
Available:https://www.wipo.int/edocs/mdocs/scp/en/scp_21/scp_21_8.pdf

Zubarev LV. Intelektualnaia sobstvennost` I svobodnoie dvizhenie tovarov. State and Law. 1998;1:66-78. Russian.

World Health Organization. Marketing Authorization of Pharmaceutical Products with Special Reference to Multisource (Generic) Products. 2nd edition. Geneva: WHO Press; 2011.
(Accessed 16 July 2020)
Available:http://apps.who.int/iris/bitstream/10665/44576/1/9789241501453_eng.pdf

Muris Timothy J. Chairman. Federal Trade Commission. To Promote Innovation: the Proper Balance of Competition and Patent Law and Policy. Washington: Federal Trade Commission; 2003.
(Accessed 16 July 2020)
Available:https://www.ftc.gov/sites/default/files/documents/reports/promote-innovation-proper-balance-competition-and-patent-law-and-policy/innovationrpt.pdf

European Court. “Kohlpharma GmbH v. Germany”.
(Accessed 16 July 2020)
Available:https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A62002CJ0112

Kerry VB, Lee K. TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? Global Health. 2007;3:3.
DOI: 10.1186/1744-8603-3-3

Federal Trade Commission. A Report: To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy. Washington, DC: Federal Trade Commission; 2003.
(Accessed 16 July 2020)
Available:https://www.ftc.gov/sites/default/files/documents/reports/promote-innovation-proper-balance-competition-and-patent-law-and-policy/innovationrpt.pdf

World Trade Organization. Canada – Patent Protection for Pharmaceutical Products. Complaint by the European Communities and their member States, WT/DS114/R; 2000.
(Accessed 16 July 2020)
Available:https://www.wto.org/english/tratop_e/dispu_e/7428d.pdf

Pro vnesennia zmin do deiakuh zakoniv Ukrainy schodo zabezpechennia likuvannia koronavirusnoi hvoroby (COVID-19). Laws of Ukraine, No. 539-IX. Official Gazette of Ukraine. 2020;29:7. Ukrainian.

Pro vnesennia zmin do deiakuh zakonodavchyh aktiv Ukrainy, spriamovanyh na zabezpechennia dodatkovyh sotsialnyh ta ekonomichnyh garantiy u zv`iazku z poshyrenniam koronavirusnoi hvoroby (COVID-19): Laws of Ukraine, No. 540-IX. Official Gazette of Ukraine. 2020;30:5. Ukrainian.
  • Abstract View: 325 times
    PDF Download: 290 times

Download Statistics

Downloads

Download data is not yet available.
  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Make a Submission / Login
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo


© Copyright 2010-Till Date, Journal of Pharmaceutical Research International. All rights reserved.